Download App
PAPER TRADE
Download App
Login
Feedback
SUNPHARMA
newsbot
Reputation: 199,970 •
Jan 20, 2023 12:51 AM
Sun Pharma to acquire US-based Concert for $576 million
Concert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patchy hair loss
The Economic Times
https://economictimes.indiatimes.com/markets/stocks/news/...
#SUNPHARMA
Vote
Comment
Share
NSE:SUNPHARMA price when posted: 1,040.55